ACHV
Price
$4.09
Change
-$0.10 (-2.39%)
Updated
Feb 4, 02:19 PM (EDT)
Capitalization
223.05M
36 days until earnings call
Intraday BUY SELL Signals
CRBU
Price
$1.53
Change
-$0.03 (-1.92%)
Updated
Feb 4, 02:33 PM (EDT)
Capitalization
146.28M
40 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ACHV vs CRBU

Header iconACHV vs CRBU Comparison
Open Charts ACHV vs CRBUBanner chart's image
Achieve Life Sciences
Price$4.09
Change-$0.10 (-2.39%)
Volume$1.65K
Capitalization223.05M
Caribou Biosciences
Price$1.53
Change-$0.03 (-1.92%)
Volume$100
Capitalization146.28M
ACHV vs CRBU Comparison Chart in %
ACHV
Daily Signal:
Gain/Loss:
CRBU
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
ACHV vs. CRBU commentary
Feb 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACHV is a Hold and CRBU is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 04, 2026
Stock price -- (ACHV: $4.19 vs. CRBU: $1.56)
Brand notoriety: ACHV and CRBU are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACHV: 108% vs. CRBU: 227%
Market capitalization -- ACHV: $223.05M vs. CRBU: $146.28M
ACHV [@Biotechnology] is valued at $223.05M. CRBU’s [@Biotechnology] market capitalization is $146.28M. The market cap for tickers in the [@Biotechnology] industry ranges from $118.13B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACHV’s FA Score shows that 0 FA rating(s) are green whileCRBU’s FA Score has 1 green FA rating(s).

  • ACHV’s FA Score: 0 green, 5 red.
  • CRBU’s FA Score: 1 green, 4 red.
According to our system of comparison, CRBU is a better buy in the long-term than ACHV.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACHV’s TA Score shows that 5 TA indicator(s) are bullish while CRBU’s TA Score has 6 bullish TA indicator(s).

  • ACHV’s TA Score: 5 bullish, 5 bearish.
  • CRBU’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, CRBU is a better buy in the short-term than ACHV.

Price Growth

ACHV (@Biotechnology) experienced а -9.11% price change this week, while CRBU (@Biotechnology) price change was +0.65% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.39%. For the same industry, the average monthly price growth was +1.48%, and the average quarterly price growth was +33.05%.

Reported Earning Dates

ACHV is expected to report earnings on Mar 12, 2026.

CRBU is expected to report earnings on Mar 16, 2026.

Industries' Descriptions

@Biotechnology (-2.39% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ACHV($223M) has a higher market cap than CRBU($146M). CRBU YTD gains are higher at: -1.887 vs. ACHV (-15.694). ACHV has higher annual earnings (EBITDA): -51.35M vs. CRBU (-142.47M). CRBU has more cash in the bank: 147M vs. ACHV (48.1M). ACHV has less debt than CRBU: ACHV (9.96M) vs CRBU (25.5M). CRBU has higher revenues than ACHV: CRBU (9.3M) vs ACHV (0).
ACHVCRBUACHV / CRBU
Capitalization223M146M153%
EBITDA-51.35M-142.47M36%
Gain YTD-15.694-1.887832%
P/E RatioN/AN/A-
Revenue09.3M-
Total Cash48.1M147M33%
Total Debt9.96M25.5M39%
FUNDAMENTALS RATINGS
ACHV: Fundamental Ratings
ACHV
OUTLOOK RATING
1..100
71
VALUATION
overvalued / fair valued / undervalued
1..100
52
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
51
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ACHVCRBU
RSI
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
65%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
83%
Momentum
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
79%
MACD
ODDS (%)
Bearish Trend 2 days ago
80%
Bullish Trend 2 days ago
85%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 13 days ago
80%
Bullish Trend 2 days ago
79%
Declines
ODDS (%)
Bearish Trend 6 days ago
84%
Bearish Trend 6 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
79%
Aroon
ODDS (%)
Bullish Trend 2 days ago
70%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ACHV
Daily Signal:
Gain/Loss:
CRBU
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EGMCF0.090.01
+8.99%
Emergent Metals Corp.
AMRQF1.790.06
+3.47%
AMAROQ LTD.
HKMPY43.43N/A
N/A
Hikma Pharmaceuticals plc.
SIGGF2.15N/A
N/A
Sigma Healthcare Limited
AVAI0.50-0.02
-3.31%
Avant Technologies Inc.

ACHV and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACHV has been loosely correlated with ALT. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if ACHV jumps, then ALT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACHV
1D Price
Change %
ACHV100%
-2.56%
ALT - ACHV
44%
Loosely correlated
-1.44%
ATNM - ACHV
39%
Loosely correlated
-1.64%
PLRX - ACHV
36%
Loosely correlated
+1.68%
RANI - ACHV
34%
Loosely correlated
+2.50%
EYPT - ACHV
33%
Poorly correlated
-3.69%
More

CRBU and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRBU has been loosely correlated with CRSP. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if CRBU jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRBU
1D Price
Change %
CRBU100%
+6.85%
CRSP - CRBU
60%
Loosely correlated
+1.34%
RXRX - CRBU
53%
Loosely correlated
-1.91%
BEAM - CRBU
52%
Loosely correlated
-0.11%
AXON - CRBU
50%
Loosely correlated
-1.89%
SYRE - CRBU
50%
Loosely correlated
+1.65%
More